Search for: "Bills v. Merck " Results 61 - 80 of 114
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2011, 9:19 pm by Marie Louise
Merck (Kluwer Patent Blog) Keppra (Levetiracetam) – US: Orange Book patent listing precipitates DJ action to trigger generic Keppra XR 180-day exclusivity forfeiture: Par Pharmaceutical v UCB et al (FDA Law Blog) (Patent Docs) Naropin (Ropivacaine) – US: Judge O’Malley in dissent: Patent assignments should be a matter of state law: Abraxis BioScience v. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
6 Jul 2011, 2:21 am by Marie Louise
  General Traditional knowledge and genetic resources – developing IPRs – 19 developing nations meet in Bali (IP Komodo Dragon) Twelve more nations, EU, sign Nagoya Protocol (IP Watch) Australia: Update on Australian Senate gene patent inquiry (Patentology) Canada: Amending Canada’s Access to Medicines Regime (CAMR): The new fate of Bill C-393 (IP Watch) EU: Negative term SPC – A handy note on Case C-125/10 Merck (The SPC Blog) (EPLAW) Italy: Milan… [read post]
23 May 2019, 9:30 pm by Alana Bevan
Court of Appeals for the Third Circuit, which held that a jury should determine if FDA would have added a warning to the labels of Merck osteoporosis drug Fosamax. [read post]
17 Jun 2018, 11:55 pm by admin
Subrogation is a fault-based legal concept which allows insurance companies paying medical bills or property damage bills to recover their payments from the third-party tortfeasor. [read post]
17 Jun 2018, 11:55 pm by admin
Subrogation is a fault-based legal concept which allows insurance companies paying medical bills or property damage bills to recover their payments from the third-party tortfeasor. [read post]
2 Nov 2011, 2:00 am by Marie Louise
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell… [read post]
22 Feb 2008, 1:30 pm
  The decision in Reidel v. [read post]
7 Dec 2009, 3:00 am
– Resale royalty rights (IP Whiteboard)   Brazil Brazilian government tailors a bill on trade sanctions (IP tango)   Canada The curious case of the actor’s performance (part two) (IP Osgoode) Private Member’s bill on copyright coming? [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
25 May 2010, 2:16 pm by David Walk
The New England Journal of Medicine bills itself as “the world’s most influential medical journal,” and it unquestionably publishes groundbreaking articles about medicine. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]